Parquet CA, Curotto-Grasiosi J, Machado RA, Peressotti B, Padilla MB, Bolaño AL

Language: Spanish
References: 19
Page: 247-251
PDF size: 267.24 Kb.

ABSTRACT

A 29-year-old man with a history of seizures, was admitted due to an episode of unconsciousness recovered and hypertension with renal disfunction. The electrocardiogram mimicked a hypertrophic cardiomyopathy, but, by Doppler echocardiography, this was discarded because it suggested endomyocardial fibrosis which was confirmed by cardiac magnetic resonance imaging with late enhancement. Since the episode of unconsciousness, brain imaging studies were performed showing vascular sequelae and microangiopathic lesions. These vascular lesions asocciated with renal disfunction with proteinuria within nephrotic range, intensified the search for the etiology arriving to the diagnosis of antiphospholipid syndrome. The patient was discharged with antihypertensive therapy, acenocoumarol, antiepileptic and immunosuppressive drugs.

REFERENCES

1. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295-306.

2. Hughes GRV. Thrombosis, absorption, cerebral disease and the lupus anticoagulant. BMJ. 1983;287:1088-9.

3. Asherson RA, Harris EN. Anticardiolipin antibodies-clinical associations. Postgrad Med J. 1986;62:1081-7.

4. Hedge VA, Vivas Y, Shah H, Haybron D, Srinivasan V, Dua A, et al. Cardiovascular surgical outcomes in patients with the antiphospholipid syndrome. A case series. Heart Lung Circ. 2007;16(6):423-7.

5. Alonso-Santor JE, Inglada-Galiana L, Pérez-Paredes G. Síndrome antifosfolípido, estado actual. An Med Interna. 2007;24:242-8.

6. Koniari J, Siminelakis SN, Baikoussis NG, Papadopoulos G, Goudevenos J, Apostolakis E. Antiphospholipid syndrome; its implication in cardiovascular disease: a review. J Cardiothorac Surg. 2010;5:101.

7. Davies JNP. Endomyocardial fibrosis in Uganda. East Afr Med J. 1948;25:10-6.

8. Mocumbi AO. Neglected cardiomyopathies in Africa. SA Heart Journal. 2009;6:30-41.

9. Sliwa K, Damasceno A, Mayosi BM. Epidemiology and etiology of cardiomyopathy in Africa. Circulation. 2005;112:3577-83.

10. Azeem T, Vassallo M, Samani N. Images in cardiology. Endomyocardial fibrosis associated with antiphospholipid syndrome. Heart. 2000;84(2):156.

11. Gonçalves LF, Souto FM, Faro FN, Oliveira JL, Barreto-Filho JA, Sousa AC. Biventricular thrombus and endomyocardial fibrosis in antiphospholipid syndrome. Arq Bras Cardiol. 2012;99(5):e162-e165.

12. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. European Heart Journal. 2012;33:1787-1847.

13. Schwitter J. Extending the frontiers of cardiac magnetic resonance. Circulation. 2008;118:109-12.

14. Raman SV, Simonetti OP. The CMR examination in heart failure. Heart Fail Clin. 2009;5:283-300.

15. Dayal NA, Isenberg DA. Endstage renal failure in primary antiphospholipid syndrome-case report and review of literature. Rheumatology. 2003;42:1128-9.

16. Polaina-Rusillo M, Biechy-Baldan MM, Vallejo- Miñarro J. Proteinuria en rango nefrótico en paciente con síndrome antifosfolípido primario. Nefrología. 2009;29(4):372-373.

17. Estornell J, López MP, Dicenta F, Igual B, Martínez V, Sonlleva A. Utilidad de la resonancia magnética en el estudio de la enfermedad endomiocárdica. Rev Esp Cardiol. 2003;56(3):321-4.

18. Cury RC, Abbara S, Sandoval LJ, Houser S, Brady TJ, Palacios IF. Images in cardiovascular medicine. Visualization of endomyocardial fibrosis by delayedenhancement magnetic resonance imaging. Circulation. 2005;111(9):e115-7.

19. Smedema JP, Winckels SKG, Snoep G, et al. Tropical endomyocardial fibrosis (Davies’ disease): case report demonstrating the role of magnetic resonance imaging. Int J Cardiovasc Imaging. 2004;20:517-22.